Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H26FN3O4 |
| Molecular Weight | 415.4579 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1COC2=C(C=CC=C2O1)N3CCN(CCNC(=O)C4=CC=C(F)C=C4)CC3
InChI
InChIKey=NYSDRDDQELAVKP-SFHVURJKSA-N
InChI=1S/C22H26FN3O4/c23-17-6-4-16(5-7-17)22(28)24-8-9-25-10-12-26(13-11-25)19-2-1-3-20-21(19)29-15-18(14-27)30-20/h1-7,18,27H,8-15H2,(H,24,28)/t18-/m0/s1
| Molecular Formula | C22H26FN3O4 |
| Molecular Weight | 415.4579 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL273 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9022796 |
1.7 nM [Ki] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Rocuronium-induced neuromuscular block after long pretreatment of clonidine in rabbits. | 2010-09 |
|
| 5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia. | 2010-08 |
|
| Chronic thromboembolic pulmonary hypertension. | 2010-04 |
|
| Peripheral 5-HT1A and 5-HT7 serotonergic receptors modulate parasympathetic neurotransmission in long-term diabetic rats. | 2010 |
|
| Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy. | 2010 |
|
| A pilot study of rizatriptan and visually-induced motion sickness in migraineurs. | 2009-08-06 |
|
| Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis. | 2008-12 |
|
| Activation of 5-HT1A autoreceptors in the dorsal raphe nucleus reduces the behavioral consequences of social defeat. | 2008-10 |
|
| Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models. | 2008-09 |
|
| Stress-induced hyperthermia and basal body temperature are mediated by different 5-HT(1A) receptor populations: a study in SERT knockout rats. | 2008-08-20 |
|
| The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. | 2008 |
|
| Acute flesinoxan treatment produces a different effect on rat brain serotonin synthesis than chronic treatment: an alpha-methyl-l-tryptophan autoradiographic study. | 2007-12 |
|
| Allometric scaling of pharmacodynamic responses: application to 5-Ht1A receptor mediated responses from rat to man. | 2007-11 |
|
| SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug. | 2007-01 |
|
| Delay aversion: effects of 7-OH-DPAT, 5-HT1A/1B-receptor stimulation and D-cycloserine. | 2006-12 |
|
| Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat. | 2006-09 |
|
| 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala. | 2006-02-17 |
|
| Contractile effects of 5-hydroxytryptamine and 5-carboxamidotryptamine in the equine jejunum. | 2006-01 |
|
| Early response and 8-week treatment outcome in GAD. | 2006 |
|
| 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior. | 2005-12-01 |
|
| Differential ion current activation by human 5-HT(1A) receptors in Xenopus oocytes: evidence for agonist-directed trafficking of receptor signalling. | 2005-12 |
|
| The effect of a 5-HT1A receptor agonist on striatal dopamine release. | 2005-08 |
|
| Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6. | 2005-04-30 |
|
| Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice. | 2004-06-21 |
|
| Effects of repeated testing in two inbred strains on flesinoxan dose-response curves in three mouse models for anxiety. | 2004-06-21 |
|
| Influence of 5-HT1 receptor agonists on feline stomach relaxation. | 2004-05-25 |
|
| Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat. | 2004-05-05 |
|
| Occupancy of agonist drugs at the 5-HT1A receptor. | 2004-05 |
|
| Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study. | 2004-03 |
|
| Mechanism-based pharmacokinetic-pharmacodynamic modeling of 5-HT1A receptor agonists: estimation of in vivo affinity and intrinsic efficacy on body temperature in rats. | 2004-03 |
|
| In vivo characterization of 5-HT1A receptor-mediated gastric relaxation in conscious dogs. | 2003-11 |
|
| Ca2+ responses in Chinese hamster ovary-K1 cells demonstrate an atypical pattern of ligand-induced 5-HT1A receptor activation. | 2003-11 |
|
| Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat. | 2003-10-08 |
|
| Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924. | 2003-09 |
|
| Modulation of 5-HT(1A) receptor-mediated Ca(2+) responses by co-expression with various recombinant G(alpha) proteins in CHO-K1 cells. | 2003-08 |
|
| Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. | 2003-07 |
|
| Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca2+ responses to partial as opposed to higher-efficacy 5-HT1A agonists. | 2003-06 |
|
| Modulation of passive avoidance in mice by the 5-HT1A receptor agonist flesinoxan: comparison with the benzodiazepine receptor agonist diazepam. | 2003-04 |
|
| Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors. | 2002-12-31 |
|
| Hormonal and temperature responses to the 5-HT1A receptor agonist flesinoxan in normal volunteers. | 2002-10 |
|
| Neuroendocrine evaluation of 5-HT1A function in male alcoholic patients. | 2002-10 |
|
| Psychopharmacology of anxiety disorders. | 2002-09 |
|
| Autonomic changes associated with enhanced anxiety in 5-HT(1A) receptor knockout mice. | 2002-09 |
|
| 5-HT1A dysfunction in borderline personality disorder. | 2002-07 |
|
| Pharmacokinetic-pharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT1A receptor agonist flesinoxan. | 2002-06-07 |
|
| The interaction between the locus coeruleus and dorsal raphe nucleus studied with dual-probe microdialysis. | 2002-06-07 |
|
| [Effect of (+/-)-pindolol on the central 5-HT1A receptor by the use of in vivo microdialysis and hippocampal slice preparations]. | 2002-06 |
|
| [Participation of 5-HT1A-receptors in regulating various types of aggressive behavior]. | 2002-03-02 |
|
| Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study. | 1998-08-21 |
|
| Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats. | 1993 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:49:37 GMT 2025
by
admin
on
Mon Mar 31 18:49:37 GMT 2025
|
| Record UNII |
3V574S89E1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47794
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Flesinoxan
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
PRIMARY | |||
|
57347
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
PRIMARY | |||
|
98206-10-1
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
PRIMARY | |||
|
SUB07640MIG
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
PRIMARY | |||
|
CHEMBL1742477
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
PRIMARY | |||
|
100000080992
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
PRIMARY | |||
|
5957
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
PRIMARY | |||
|
3V574S89E1
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
PRIMARY | |||
|
C056895
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
PRIMARY | |||
|
m1163
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
PRIMARY | Merck Index | ||
|
C80760
Created by
admin on Mon Mar 31 18:49:37 GMT 2025 , Edited by admin on Mon Mar 31 18:49:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |